Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB044A | — |
Inadvertent administration of Only the Liquid Conjugate Component of the 2-vial Presentation of Menveo to a patient.; Inadvertent Administration of Only the Liquid Conjugate Component of the 2-vial Presentation of Menveo to a patient.; received a previous vaccination with Menveo two vial full dose/administered a Menveo two vial liquid component; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB044A, expiry date 31-JUL-2025) for prophylaxis. Previously administered products included Menveo (received a previous vaccination with Menveo two vial full dose a couple of years before). On 21-JUL-2025, the patient received Menveo. On 21-JUL-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Inadvertent administration of Only the Liquid Conjugate Component of the 2-vial Presentation of Menveo to a patient.), inappropriate dose of vaccine administered (Verbatim: Inadvertent Administration of Only the Liquid Conjugate Component of the 2-vial Presentation of Menveo to a patient.) and extra dose administered (Verbatim: received a previous vaccination with Menveo two vial full dose/administered a Menveo two vial liquid component). The outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and extra dose administered were not applicable. Additional Information: GSK Receipt Date: 23-JUL-2025 Clinic director called to ask about guidance because one of the medical assistant as at the facility administered only the liquid conjugate component of the 2-vial presentation of Menveo (as a third dose) to a patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered, and extra dose administered. The reporter wants to asked do the patient need to revaccinate or not. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.